pbmcs isolated using lymphoprep Search Results


99
NSJ Bioreagents cd3 antibody
Cd3 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd3 antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
cd3 antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
AbCys s a lymphoprep
Lymphoprep, supplied by AbCys s a, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep/product/AbCys s a
Average 90 stars, based on 1 article reviews
lymphoprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Axis-Shield Diagnostics lymphoprep™
Lymphoprep™, supplied by Axis-Shield Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep™/product/Axis-Shield Diagnostics
Average 90 stars, based on 1 article reviews
lymphoprep™ - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc sepmate pbmc isolation tubes
Sepmate Pbmc Isolation Tubes, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sepmate pbmc isolation tubes/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
sepmate pbmc isolation tubes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Abbott Laboratories lymphoprep
Lymphoprep, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
lymphoprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep
Lymphoprep, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nycomed lymphoprep 1077
Lymphoprep 1077, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep 1077/product/Nycomed
Average 90 stars, based on 1 article reviews
lymphoprep 1077 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc peripheral blood mononuclear cell isolation lymphoprep
Peripheral Blood Mononuclear Cell Isolation Lymphoprep, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peripheral blood mononuclear cell isolation lymphoprep/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
peripheral blood mononuclear cell isolation lymphoprep - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc lymphoprep 07801
( A ) Experimental design: Donor <t>PBMCs</t> isolated from women with or without a history of EBV infection or an RRMS diagnosis were used to engraft immunocompromised NSG mice. Following a 3-week reconstitution period and confirmation of circulating human CD45 + cell repopulation, humanized NSG mice (HuPBMC) were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) antigens to induce EAE. ( B ) Donor serum IgG specific to acute EBV antigen viral capsid antigen (VCA). ( C ) Donor serum immunoglobulin G (IgG) specific to latent EBV antigen Epstein-Barr nuclear antigen 1 (EBNA-1). In (B) and (C), group data are shown as means with SEM and were curve fit with a one-site total binding equation. Statistical differences in titer curves were assessed by ordinary two-way analysis of variance (ANOVA). ( D ) Cell-associated EBV viral loads in donor PBMCs measured by BALF5 quantitative polymerase chain reaction (qPCR) assay. Data are shown as means with SEM and were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. In (B) to (D), n = 3 to 4 donors per group and the lower limit of detection (LOD) for each assay is represented by a dotted line. ( E ) Clinical disease scores post-induction for symptomatic HuPBMC EAE mice. Data are shown as means with SEM, and curves were analyzed by ordinary two-way ANOVA ( n = 17 to 25 mice per group derived from three to four donors per group). ( F ) Incidence of clinical EAE symptoms post-induction. Data are shown as percentage of the group, and curves were analyzed by log-rank (Mantel-Cox) test ( n = 54 to 62 mice per group derived from three to four donors per group). ( G ) Day of EAE symptom onset post-induction (DPI). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test ( n = 17 to 25 mice per group derived from three to four donors per group).
Lymphoprep 07801, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lymphoprep 07801/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
lymphoprep 07801 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc density gradient centrifugation lymphoprep and pbmc isolation tubes
( A ) Experimental design: Donor <t>PBMCs</t> isolated from women with or without a history of EBV infection or an RRMS diagnosis were used to engraft immunocompromised NSG mice. Following a 3-week reconstitution period and confirmation of circulating human CD45 + cell repopulation, humanized NSG mice (HuPBMC) were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) antigens to induce EAE. ( B ) Donor serum IgG specific to acute EBV antigen viral capsid antigen (VCA). ( C ) Donor serum immunoglobulin G (IgG) specific to latent EBV antigen Epstein-Barr nuclear antigen 1 (EBNA-1). In (B) and (C), group data are shown as means with SEM and were curve fit with a one-site total binding equation. Statistical differences in titer curves were assessed by ordinary two-way analysis of variance (ANOVA). ( D ) Cell-associated EBV viral loads in donor PBMCs measured by BALF5 quantitative polymerase chain reaction (qPCR) assay. Data are shown as means with SEM and were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. In (B) to (D), n = 3 to 4 donors per group and the lower limit of detection (LOD) for each assay is represented by a dotted line. ( E ) Clinical disease scores post-induction for symptomatic HuPBMC EAE mice. Data are shown as means with SEM, and curves were analyzed by ordinary two-way ANOVA ( n = 17 to 25 mice per group derived from three to four donors per group). ( F ) Incidence of clinical EAE symptoms post-induction. Data are shown as percentage of the group, and curves were analyzed by log-rank (Mantel-Cox) test ( n = 54 to 62 mice per group derived from three to four donors per group). ( G ) Day of EAE symptom onset post-induction (DPI). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test ( n = 17 to 25 mice per group derived from three to four donors per group).
Density Gradient Centrifugation Lymphoprep And Pbmc Isolation Tubes, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/density gradient centrifugation lymphoprep and pbmc isolation tubes/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
density gradient centrifugation lymphoprep and pbmc isolation tubes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
NSJ Bioreagents cd3 epsilon antibody
( A ) Experimental design: Donor <t>PBMCs</t> isolated from women with or without a history of EBV infection or an RRMS diagnosis were used to engraft immunocompromised NSG mice. Following a 3-week reconstitution period and confirmation of circulating human CD45 + cell repopulation, humanized NSG mice (HuPBMC) were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) antigens to induce EAE. ( B ) Donor serum IgG specific to acute EBV antigen viral capsid antigen (VCA). ( C ) Donor serum immunoglobulin G (IgG) specific to latent EBV antigen Epstein-Barr nuclear antigen 1 (EBNA-1). In (B) and (C), group data are shown as means with SEM and were curve fit with a one-site total binding equation. Statistical differences in titer curves were assessed by ordinary two-way analysis of variance (ANOVA). ( D ) Cell-associated EBV viral loads in donor PBMCs measured by BALF5 quantitative polymerase chain reaction (qPCR) assay. Data are shown as means with SEM and were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. In (B) to (D), n = 3 to 4 donors per group and the lower limit of detection (LOD) for each assay is represented by a dotted line. ( E ) Clinical disease scores post-induction for symptomatic HuPBMC EAE mice. Data are shown as means with SEM, and curves were analyzed by ordinary two-way ANOVA ( n = 17 to 25 mice per group derived from three to four donors per group). ( F ) Incidence of clinical EAE symptoms post-induction. Data are shown as percentage of the group, and curves were analyzed by log-rank (Mantel-Cox) test ( n = 54 to 62 mice per group derived from three to four donors per group). ( G ) Day of EAE symptom onset post-induction (DPI). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test ( n = 17 to 25 mice per group derived from three to four donors per group).
Cd3 Epsilon Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd3 epsilon antibody/product/NSJ Bioreagents
Average 99 stars, based on 1 article reviews
cd3 epsilon antibody - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


( A ) Experimental design: Donor PBMCs isolated from women with or without a history of EBV infection or an RRMS diagnosis were used to engraft immunocompromised NSG mice. Following a 3-week reconstitution period and confirmation of circulating human CD45 + cell repopulation, humanized NSG mice (HuPBMC) were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) antigens to induce EAE. ( B ) Donor serum IgG specific to acute EBV antigen viral capsid antigen (VCA). ( C ) Donor serum immunoglobulin G (IgG) specific to latent EBV antigen Epstein-Barr nuclear antigen 1 (EBNA-1). In (B) and (C), group data are shown as means with SEM and were curve fit with a one-site total binding equation. Statistical differences in titer curves were assessed by ordinary two-way analysis of variance (ANOVA). ( D ) Cell-associated EBV viral loads in donor PBMCs measured by BALF5 quantitative polymerase chain reaction (qPCR) assay. Data are shown as means with SEM and were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. In (B) to (D), n = 3 to 4 donors per group and the lower limit of detection (LOD) for each assay is represented by a dotted line. ( E ) Clinical disease scores post-induction for symptomatic HuPBMC EAE mice. Data are shown as means with SEM, and curves were analyzed by ordinary two-way ANOVA ( n = 17 to 25 mice per group derived from three to four donors per group). ( F ) Incidence of clinical EAE symptoms post-induction. Data are shown as percentage of the group, and curves were analyzed by log-rank (Mantel-Cox) test ( n = 54 to 62 mice per group derived from three to four donors per group). ( G ) Day of EAE symptom onset post-induction (DPI). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test ( n = 17 to 25 mice per group derived from three to four donors per group).

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: ( A ) Experimental design: Donor PBMCs isolated from women with or without a history of EBV infection or an RRMS diagnosis were used to engraft immunocompromised NSG mice. Following a 3-week reconstitution period and confirmation of circulating human CD45 + cell repopulation, humanized NSG mice (HuPBMC) were immunized with recombinant human myelin oligodendrocyte glycoprotein (rhMOG) antigens to induce EAE. ( B ) Donor serum IgG specific to acute EBV antigen viral capsid antigen (VCA). ( C ) Donor serum immunoglobulin G (IgG) specific to latent EBV antigen Epstein-Barr nuclear antigen 1 (EBNA-1). In (B) and (C), group data are shown as means with SEM and were curve fit with a one-site total binding equation. Statistical differences in titer curves were assessed by ordinary two-way analysis of variance (ANOVA). ( D ) Cell-associated EBV viral loads in donor PBMCs measured by BALF5 quantitative polymerase chain reaction (qPCR) assay. Data are shown as means with SEM and were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. In (B) to (D), n = 3 to 4 donors per group and the lower limit of detection (LOD) for each assay is represented by a dotted line. ( E ) Clinical disease scores post-induction for symptomatic HuPBMC EAE mice. Data are shown as means with SEM, and curves were analyzed by ordinary two-way ANOVA ( n = 17 to 25 mice per group derived from three to four donors per group). ( F ) Incidence of clinical EAE symptoms post-induction. Data are shown as percentage of the group, and curves were analyzed by log-rank (Mantel-Cox) test ( n = 54 to 62 mice per group derived from three to four donors per group). ( G ) Day of EAE symptom onset post-induction (DPI). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test ( n = 17 to 25 mice per group derived from three to four donors per group).

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Isolation, Infection, Biomarker Discovery, Recombinant, Binding Assay, Real-time Polymerase Chain Reaction, Derivative Assay

 PBMC  donor demographics, disease characteristics, and serology. All RRMS and healthy donors were female. RRMS participants were treatment naïve and in clinical remission at the time of donation. HD, healthy donor; EDSS, expanded disability status scale; VCA, viral capsid antigen; EBNA-1, Epstein-Barr nuclear antigen 1; CMV, cytomegalovirus; NA, not applicable.

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: PBMC donor demographics, disease characteristics, and serology. All RRMS and healthy donors were female. RRMS participants were treatment naïve and in clinical remission at the time of donation. HD, healthy donor; EDSS, expanded disability status scale; VCA, viral capsid antigen; EBNA-1, Epstein-Barr nuclear antigen 1; CMV, cytomegalovirus; NA, not applicable.

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques:

( A ) Demyelination of the spinal cord in the HuPBMC EAE model. Perfused spinal cords were obtained days 19 to 25 post-induction (5 to 8 days post–symptom onset) from HuPBMC EAE mice and days 15 to 25 post-induction from NOD EAE mice (5 to 15 days post–symptom onset). Eriochrome cyanine–stained sections (top) obtained from the lower thoracic region of the spinal cord show representative myelination indices (MI) for each of the respective group means. Individual data points represent averages of serial sections sampled from four to six equidistant regions along the entire length of the spinal cord ( n = 18 regional points from three unengrafted NSG control mice; n = 22 to 36 regional points from five to six mice per group for EAE-induced NOD and HuPBMC groups). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Kruskal-Wallis with Dunn’s multiple comparisons test. ( B to D ) Human CD8 + cells infiltrate the CNS of HuPBMC EAE mice engrafted with RRMS donor PBMCs. Representative images of lumbar spinal cord (B) and cerebellar (C and D) sections from an unengrafted control NSG mouse (left) and a symptomatic HuPBMC EAE mouse (right) derived from a donor with RRMS. Perfused tissues were collected day 15 post–EAE induction (day 4 post–symptom onset). Sections were labeled with FluoroMyelin (green), NeuroTrace 530/615 (red), 4′,6-diamidino-2-phenylindole (DAPI; blue), anti-hCD8 (yellow), and anti–Iba-1 (light blue). Example hCD8 + cells are indicated by white arrowheads (B and C), and hCD8 + cells in proximity to Iba-1 + cells by red arrowheads (D). Scale bars indicate size as specified per panel, showing (A) 200 μm; (B) 200 μm and (insets) 50 μm; (C) 500 μm and (insets) 50 μm; and (D) 100 μm and (inset) 50 μm.

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: ( A ) Demyelination of the spinal cord in the HuPBMC EAE model. Perfused spinal cords were obtained days 19 to 25 post-induction (5 to 8 days post–symptom onset) from HuPBMC EAE mice and days 15 to 25 post-induction from NOD EAE mice (5 to 15 days post–symptom onset). Eriochrome cyanine–stained sections (top) obtained from the lower thoracic region of the spinal cord show representative myelination indices (MI) for each of the respective group means. Individual data points represent averages of serial sections sampled from four to six equidistant regions along the entire length of the spinal cord ( n = 18 regional points from three unengrafted NSG control mice; n = 22 to 36 regional points from five to six mice per group for EAE-induced NOD and HuPBMC groups). Distribution of individual data is shown with median and quartiles (dashed lines) and was analyzed by Kruskal-Wallis with Dunn’s multiple comparisons test. ( B to D ) Human CD8 + cells infiltrate the CNS of HuPBMC EAE mice engrafted with RRMS donor PBMCs. Representative images of lumbar spinal cord (B) and cerebellar (C and D) sections from an unengrafted control NSG mouse (left) and a symptomatic HuPBMC EAE mouse (right) derived from a donor with RRMS. Perfused tissues were collected day 15 post–EAE induction (day 4 post–symptom onset). Sections were labeled with FluoroMyelin (green), NeuroTrace 530/615 (red), 4′,6-diamidino-2-phenylindole (DAPI; blue), anti-hCD8 (yellow), and anti–Iba-1 (light blue). Example hCD8 + cells are indicated by white arrowheads (B and C), and hCD8 + cells in proximity to Iba-1 + cells by red arrowheads (D). Scale bars indicate size as specified per panel, showing (A) 200 μm; (B) 200 μm and (insets) 50 μm; (C) 500 μm and (insets) 50 μm; and (D) 100 μm and (inset) 50 μm.

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Staining, Control, Derivative Assay, Labeling

( A ) Total human CD45 + immune cell counts, ( B ) hCD19 + B cell counts, ( C ) hCD3 + T cell counts, ( D ) EBV genome copies in splenic DNA, ( E ) hCD3 + CD4 + T cell counts, and ( F ) hCD3 + CD8 + T cell counts in whole brains, spinal cords, and spleens of recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis. Perfused organs were collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset). For total immune cell quantification, n = 29 to 35 mice per group derived from two to three donors per group. For viral load quantification, n = 28 to 53 mice per group derived from two to four blood donors per group; n = 5 replicates for control EBV + B95-8 cell line, and assay lower limit of detection is represented by a dashed line. All data are shown as means with SEM and were analyzed by Kruskal-Wallis with Dunn’s multiple comparisons test.

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: ( A ) Total human CD45 + immune cell counts, ( B ) hCD19 + B cell counts, ( C ) hCD3 + T cell counts, ( D ) EBV genome copies in splenic DNA, ( E ) hCD3 + CD4 + T cell counts, and ( F ) hCD3 + CD8 + T cell counts in whole brains, spinal cords, and spleens of recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis. Perfused organs were collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset). For total immune cell quantification, n = 29 to 35 mice per group derived from two to three donors per group. For viral load quantification, n = 28 to 53 mice per group derived from two to four blood donors per group; n = 5 replicates for control EBV + B95-8 cell line, and assay lower limit of detection is represented by a dashed line. All data are shown as means with SEM and were analyzed by Kruskal-Wallis with Dunn’s multiple comparisons test.

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Biomarker Discovery, Derivative Assay, Control

Figure shows whole brain and spinal cord infiltration and spleen reconstitution in recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis. ( A ) Concatenated flow cytometric plots of IFN-γ and IL-17A expression, showing the mean frequency of hCD3 + CD4 + cells ± SD, as well as corresponding total ( B ) IFN-γ + (IL-17A − ), ( C ) IL-17A + (IFN-γ − ), and ( D ) IFN-γ + IL-17A + hCD4 + T cell counts in each tissue. ( E ) Concatenated flow cytometric plots of IFN-γ and GzmB expression, showing the mean frequency of hCD3 + CD8 + cells ± SD, quantified as ( F ) %IFN-γ + (GzmB − ), ( G ) %GzmB + (IFN-γ − ), and ( H ) %IFN-γ + GzmB + of hCD3 + CD8 + cells in each tissue. Perfused organs were collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset). Isolated immune cells were stimulated with PMA and ionomycin for cytokine detection ( n = 9 to 20 mice per group derived from one to two donors per group). All plotted data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test or by Kruskal-Wallis with Dunn’s multiple comparisons test.

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: Figure shows whole brain and spinal cord infiltration and spleen reconstitution in recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis. ( A ) Concatenated flow cytometric plots of IFN-γ and IL-17A expression, showing the mean frequency of hCD3 + CD4 + cells ± SD, as well as corresponding total ( B ) IFN-γ + (IL-17A − ), ( C ) IL-17A + (IFN-γ − ), and ( D ) IFN-γ + IL-17A + hCD4 + T cell counts in each tissue. ( E ) Concatenated flow cytometric plots of IFN-γ and GzmB expression, showing the mean frequency of hCD3 + CD8 + cells ± SD, quantified as ( F ) %IFN-γ + (GzmB − ), ( G ) %GzmB + (IFN-γ − ), and ( H ) %IFN-γ + GzmB + of hCD3 + CD8 + cells in each tissue. Perfused organs were collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset). Isolated immune cells were stimulated with PMA and ionomycin for cytokine detection ( n = 9 to 20 mice per group derived from one to two donors per group). All plotted data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test or by Kruskal-Wallis with Dunn’s multiple comparisons test.

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Biomarker Discovery, Expressing, Isolation, Derivative Assay

The proportion of hCD3 + CD4 + T cells expressing FOXP3 in ( A ) freshly isolated donor PBMC ( n = 3 to 4 donors per group), ( B ) in the peripheral blood of engrafted HuPBMC mice at 3 weeks post–PBMC injection ( n = 57 to 62 mice per group derived from three to four donors per group), and in the ( C ) brain, ( D ) spinal cord, and ( E ) spleen of HuPBMC EAE mice at endpoint ( n = 30 to 35 mice per group derived from two to three donors per group). The ratio of infiltrating ( F ) hCD4 + IFN-γ + (T H 1) and ( G ) hCD8 + IFN-γ + GzmB + (T c ) to regulatory hCD4 + FOXP3 + (T reg ) cells per tissue in recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis ( n = 7 to 20 mice per group from one to two donors per group). Cells were isolated from perfused organs collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset) and, for cytokine detection, stimulated with PMA and ionomycin. Data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test (A) or by Kruskal-Wallis with Dunn’s multiple comparisons test [(B) to (G)].

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: The proportion of hCD3 + CD4 + T cells expressing FOXP3 in ( A ) freshly isolated donor PBMC ( n = 3 to 4 donors per group), ( B ) in the peripheral blood of engrafted HuPBMC mice at 3 weeks post–PBMC injection ( n = 57 to 62 mice per group derived from three to four donors per group), and in the ( C ) brain, ( D ) spinal cord, and ( E ) spleen of HuPBMC EAE mice at endpoint ( n = 30 to 35 mice per group derived from two to three donors per group). The ratio of infiltrating ( F ) hCD4 + IFN-γ + (T H 1) and ( G ) hCD8 + IFN-γ + GzmB + (T c ) to regulatory hCD4 + FOXP3 + (T reg ) cells per tissue in recipient HuPBMC EAE mice at endpoint, grouped by PBMC donor EBV serostatus and RRMS diagnosis ( n = 7 to 20 mice per group from one to two donors per group). Cells were isolated from perfused organs collected days 14 to 27 post–EAE induction (average 5 to 10 days post–symptom onset) and, for cytokine detection, stimulated with PMA and ionomycin. Data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test (A) or by Kruskal-Wallis with Dunn’s multiple comparisons test [(B) to (G)].

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Expressing, Isolation, Injection, Derivative Assay, Biomarker Discovery

Previously frozen, whole PBMC samples from EBV + RRMS, EBV + HD, and EBV − HD blood donors were incubated with anti-CD3/CD28–coated beads for 96 hours to stimulate T cells in the absence of a specific antigen. Figure shows ( A ) the proliferation index determined by CFSE staining, ( B ) the proportion of hCD4 + T cells having undergone a specified number of cellular divisions by CFSE staining, ( C ) Ki-67 expression, ( D ) Tumor necrosis factor–α (TNFα) expression, and ( E ) IFN-γ and IL-17A expression on hCD3 + CD4 + T cells, as well as ( F ) the proliferation index determined by CFSE staining, ( G ) the proportion of hCD8 + T cells having undergone a specified number of cellular divisions by CFSE staining, ( H ) Ki-67 expression, ( I ) TNFα expression, and ( J ) IFN-γ expression on hCD3 + CD8 + T cells. Concatenated flow plots indicate the sum proportion of marker positive cells for all donors in each group. The colored symbol legend is applicable to all comparisons ( n = 3 to 4 blood donors per group). All plotted data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test or by Kruskal-Wallis with Dunn’s multiple comparisons test.

Journal: Science Advances

Article Title: Epstein-Barr virus infection promotes T cell dysregulation in a humanized mouse model of multiple sclerosis

doi: 10.1126/sciadv.adu5110

Figure Lengend Snippet: Previously frozen, whole PBMC samples from EBV + RRMS, EBV + HD, and EBV − HD blood donors were incubated with anti-CD3/CD28–coated beads for 96 hours to stimulate T cells in the absence of a specific antigen. Figure shows ( A ) the proliferation index determined by CFSE staining, ( B ) the proportion of hCD4 + T cells having undergone a specified number of cellular divisions by CFSE staining, ( C ) Ki-67 expression, ( D ) Tumor necrosis factor–α (TNFα) expression, and ( E ) IFN-γ and IL-17A expression on hCD3 + CD4 + T cells, as well as ( F ) the proliferation index determined by CFSE staining, ( G ) the proportion of hCD8 + T cells having undergone a specified number of cellular divisions by CFSE staining, ( H ) Ki-67 expression, ( I ) TNFα expression, and ( J ) IFN-γ expression on hCD3 + CD8 + T cells. Concatenated flow plots indicate the sum proportion of marker positive cells for all donors in each group. The colored symbol legend is applicable to all comparisons ( n = 3 to 4 blood donors per group). All plotted data are shown as means with SEM and were analyzed by Brown-Forsythe and Welch ANOVA with Dunnett’s T3 multiple comparisons test or by Kruskal-Wallis with Dunn’s multiple comparisons test.

Article Snippet: Whole blood (80 ml) was processed for PBMC isolation by Lymphoprep (STEMCELL Technologies, no. 07801) gradient separation, according to the manufacturer’s instructions, within an hour of collection in K 2 -EDTA–coated vacutainer tubes (BD, no. 366643).

Techniques: Incubation, Staining, Expressing, Marker